Patents Assigned to ABREOS BIOSCIENCES, INC.
  • Detection and quantification of natalizumab
    Patent number: 11680948
    Abstract: Methods and assays for detecting natalizumab in a sample, natalizumab-peptide complexes in a sample, and point-of-care devices for detecting natalizumab in a sample are described herein.
    Type: Grant
    Filed: August 11, 2017
    Date of Patent: June 20, 2023
    Assignee: ABREOS BIOSCIENCES, INC.
    Inventors: Bradley T. Messmer, Dina Uzri, Jessie-Farah Fecteau
  • Point-of-care diagnostic device
    Patent number: D800912
    Type: Grant
    Filed: June 17, 2016
    Date of Patent: October 24, 2017
    Assignee: ABREOS BIOSCIENCES, INC.
    Inventors: Dina Uzri, Benedict L. Zin, Bradley Todd Messmer, Inhoe Kim, Gad Shaanan, Jessie-Farah Fecteau